Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving temozolomide together with thalidomide works
in treating patients with brain metastases secondary to melanoma. Drugs used in chemotherapy,
such as temozolomide, work in different ways to stop tumor cells from dividing so they stop
growing or die. Thalidomide may stop the growth of cancer by stopping blood flow to the
tumor. Combining temozolomide with thalidomide may kill more tumor cells